News
In EARLY TAVR, intervention improved outcomes over waiting in patients with class II or no indications for AVR consideration.
The medtech startup is seeking funding for clinical trials to bring its catheter-based technique to more patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback